febuxostat has been researched along with Arrhythmias, Cardiac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Chen, M; Cui, C; Lin, Z; Liu, H; Qin, H; Zheng, B; Zhu, Y | 1 |
| Chang, NC; Lee, TM; Lin, SZ | 1 |
2 other study(ies) available for febuxostat and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Febuxostat Increases Ventricular Arrhythmogenesis Through Calcium Handling Dysregulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Allopurinol; Arrhythmias, Cardiac; Calcium; Extracellular Signal-Regulated MAP Kinases; Febuxostat; Humans; Induced Pluripotent Stem Cells; JNK Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Uric Acid; Xanthine Oxidase | 2022 |
Effects of urate-lowering agents on arrhythmia vulnerability in post-infarcted rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Febuxostat; GAP-43 Protein; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Rats; Rats, Wistar; Superoxides; Tyrosine 3-Monooxygenase; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2016 |